Cantor Fitzgerald Downgrades Sucampo Pharmaceuticals To Hold

Cantor Fitzgerald downgraded Sucampo Pharmaceuticals, Inc. SCMP from Buy to Hold. The price target for Sucampo Pharmaceuticals is set to $18. Sucampo Pharmaceuticals shares have gained 155.09 percent over the past 52 weeks, while the S&P 500 index has surged 10.90 percent in the same period. Sucampo Pharmaceuticals' shares climbed 2.91 percent to close at $18.06 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsCantor Fitzgerald
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!